Cervical pessary use and preterm birth: How little we know
Magee Womens Hospital, Pittsburgh, PA 15213, USA.The Lancet (Impact Factor: 45.22). 04/2012; 379(9828):1769-70. DOI: 10.1016/S0140-6736(12)60116-0
- Gynécologie Obstétrique & Fertilité 04/2013; 41(4):260–261. DOI:10.1016/j.gyobfe.2013.02.014 · 0.52 Impact Factor
- Gynécologie Obstétrique & Fertilité 04/2013; · 0.52 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Preterm birth remains a considerable public health concern and priority. Little headway has been made in the prevention of preterm birth despite considerable research in this area. New ideas and treatments are desperately needed. The pessary has emerged as a possible treatment for the prevention of preterm birth in both singleton and twin gestations. It appears to be low cost with minimal side effects. This review focuses on the available evidence for the use of cervical pessaries for the prevention of preterm birth, especially in a high-risk population with a shortened cervical length. Larger scale randomized-controlled trials are warranted before incorporation of the pessary into standard obstetrical practice.Clinical Obstetrics and Gynecology 06/2014; 57(3). DOI:10.1097/GRF.0000000000000036 · 1.77 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.